Is TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors superior to TACE plus tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: the debate continues
医学
肝细胞癌
肝病学
酪氨酸激酶
癌症研究
内科学
蛋白酪氨酸激酶
酪氨酸激酶抑制剂
癌症
受体
作者
Shiye Yang,Huoqi Liang,Xing Li,Jiayi Qian,Zhibing Ming